Tetrahydrofuran (THF) and tetrahydropyran (THP) rings are commonly found in a wide range of natural products and biologically active compounds. In total synthesis, the formation of THF/THP motifs is often the key step but existing methods often involve numerous steps and low overall efficiencies. Part one of this thesis details the development of a practical method for the synthesis of THF rings by the controlled mono-addition/cyclisation of organolithium species to C2-symmetric diepoxides (Scheme A-1). This method can also be applied to the synthesis of bis-THF rings from triepoxides and has potential applications in more complex cascade reactions. A similar cyclisation process providing THF rings from epoxyaldehydes is also described. Part two of this thesis details our efforts towards the synthesis of the marine macrolide neopeltolide. Wright and co-workers reported the isolation of neopeltolide 211 from a deep-water sponge of the family neopeltidae off the north coast of Jamaica. The structure, which was assigned by NMR and HRMS studies and reassigned by total synthesis, contains a 14-membered macrolactone, a 2,6-cis THP ring and an unsaturated oxazole side-chain. Chapter four describes the synthesis of the C2-C8 and C9-C16 fragments (Scheme A-2). Chapter five details our initial attempts in the coupling of subunits 268 and 320, as well as a revised synthetic strategy that allowed us to successfully couple C2-C9 alkyne 347 with C10-C16 aldehyde 348 and the preparation of an advanced intermediate 364 (Scheme A-3).

Streptomyces is the largest antibiotic-producing genus in the microbial world. Manumycin-type antibiotics are a small group of its metabolites. Their antibiotic activities are not very important but they show biological properties which can be potencially used e. g. to treat inflammation, cancer or Alzheimer's disease. The structure of manumycin compounds is formed by a central unit with connected upper and lower polyketide chain. The lower chain is mostly terminated by so called C5N unit. The substance U-62162 produced by the strain Streptomyces verdensis differs significantly from the other members of the manumycin-type metabolites in the structure of the lower chain which is fully saturated and lacking the C5N unit. The U-62162 biosynthetic gene cluster was sequenced and functions of identified open reading frames were deduced. Heterologous expressions of the cluster showed some genes reguired for the biosynthesis of the upper chain to be encoded on a different part of the chromosome. The insertional inactivation of the vrdER gene confirmed the enoylreductase to be responsible for the saturation of the lower chain. DSBA oxidoreductase, which gene is located at the edge of the cluster, is probably not involved in the biosynthesis. The insertion of genes for the biosynthesis of the C5N unit did...

1 Abstract: Secondary metabolism of Gram-positive soil bacteria from the genus Streptomyces is a inestimable source of natural products including manumycins, which belong to a polyketide group. These products possess weak antimicrobial, but important antiinflammatory, and antitumor activities. Streptomyces sp. offers broad amounts of yet undiscovered antibiotics, potentially utilizable in clinical medicine. This fact makes out of these organisms a promising solution to our present problem with rising antibiotic resistance among microorganisms. Two main ways are applied in this research: There are efforts of prepairing new derivates based on known products and creating various modifications in their structure. Next, new producers are discovered by "genome mining" methods, activation of silent gene clusters, followed by improvements of antibiotic production. One of those silent clusters was found in the Saccharothrix espanaensis DSM44229 strain. The genetic information has been transferred to a heterologous host in order to characterize its product. Cluster activation and production of novel manumycin-type metabolites occurred in the host after the transfer.

Manumycin antibiotics represent an important class of secondary metabolites produced by Streptomyces bacteria. They belong to a big class of polyketide metabolites and posses significant antimicrobial, anti-inflammatory, antitumor, and many other biological activities. They are characterized by two short polyketide chains, which are attached to a central subunit. Polyketide chains are synthesized by enzymes of the iterative type II polyketide-synthase. Mechanism of regulation of the polyketide chains length has not been known yet. Understanding mechanism can lead to biosynthesis of novel manumycin antibiotics with predetermined chain lengths what may improve their biological activities in favour of a practical use of these compounds. We prepared a mutant strain of asukamycin producer Streptomyces nodosus ssp. asukaensis with deletion of genes coding for type I/II β-ketoacylsynthase and protein AsuC14, which is a potential factor affecting lower polyketide chain length, for the identification of the chain length factor in manumycin antibiotics producers. Next, the genes for type I/II β-ketoacylsynthase and potential chain length-affecting factor C14 from strains producing manumycins with variable length of the lower polyketide chains were expressed in this mutant strain. Our results demonstrate...

In 2004, the polyketide natural product, chamuvarinin (72) was isolated by Laurens et al. from the roots of Uvaria chamae, a member of the Annonaceae plant family. This unique tetrahydropyran containing acetogenin displayed potent levels of cytotoxic activity against the KB 3-1 cell line with an ED50 value of 0.8 nM. Upon initial isolation the relative and absolute stereochemical assignment of chamuvarinin (72) was unable to be readily achieved through ¹H and ¹³C NMR analysis. The initial synthetic route described herein has enabled the relative and absolute stereochemical determination of chamuvarinin (72) through the first total synthesis completed in 20 longest linear steps in 1.5% overall yield. A revised synthetic strategy towards chamuvarinin (72) was completed in 17 longest linear steps in 2.2% overall yield. The revised route facilitated the assembly of non-natural chamuvarinin-like analogues and their trypanocidal and cytotoxic activities have been assessed. The synthesis of these analogues has formed the basis of a more focussed study through the design and synthesis of simplified triazole (295), isoxazole (325) and butenolide triazole (305) analogues as potential Trypanosoma brucei (causative agent in African Sleeping sickness) inhibitors.

Os micro-organismos são profícuas fontes de produtos naturais bioativos. Diversos fármacos de importância clínica são de origem microbiana, sendo que a maioria dos antibióticos usados clinicamente é produzida por actinobactérias, principalmente do gênero Streptomyces. A resistência a múltiplas drogas por microorganismos patogênicos e também pelas células tumorais leva à necessidade por novos fármacos antibacterianos e antitumorais. Actinobactérias endofíticas têm demonstrado grande potencial para a busca de produtos naturais bioativos. O presente trabalho relata o estudo químico de duas linhagens de actinobactérias endofíticas, Streptomyces sp. RTd 22 e Streptomyces sp RTd 31, isoladas das raízes de Tithonia diversifolia. As frações ativas nos ensaios biológicos foram fracionadas para a identificação dos compostos bioativos, sendo eles os antibióticos macrolídeos concanamicinas A (S31-1) e B (S31-2), anidro-agliconas das concanamicinas A (S31-3) e B (S31-4), todos produzidos por Streptomyces sp RTd31, e o ionóforo poliéter grisorixina (S22-2), produzido por Streptomyces sp. RTd22. Foi realizado o monitoramento da produção desses compostos bioativos por UPLC-MS através do modo SIM. As concanamicinas A e B tiveram um máximo de produção com 96h, já a grisorixina obteve um máximo com 192h. Outros compostos identificados por desreplicação dos extratos butanólicos de ambas as actinobactérias foram os sideróforos norcardamina (S31-7) e desoxi-nocardamina (S31-8), já o sideróforo desferrioxamina B (S31-9) foi identificado apenas nos extratos butanólicos de Streptomyces sp RTd31. Experimentos de variação do meio de cultivo e co-cultura com bactérias patogênicas foram empregados a fim de estimular a biossíntese de novos compostos, porém nenhum novo metabólito foi identificado. O sequenciamento genético da actinobactéria Streptomyces sp. RTd22 permitiu verificar a presença de vários clusters biossintéticos nesse micro-organismo através da análise feita pelo antiSMASH. Foi possível identificar o cluster da himastatina (S22-4) e da coeliquelina (S22-5), sendo que ambos os compostos não foram biossintetizados nas condições de cultivo utilizadas. O cluster biossintético da grisorixina foi determinado e o experimento de recombinação homóloga para a deleção do gene análogo a flavina mono-oxigenase da nigericina nigC foi realizado. Dois mutantes foram obtidos e um deles foi cultivado para a análise do perfil metabólico por espectrometria de massas. Não houve a produção da grisorixina nem do seu possível precursor pelo mutante, mas outros metabólitos foram produzidos / Microorganisms are prolific sources of bioactive natural products. Several clinically important drugs have microbial origin, and most of the therapeutically used antibiotics are produced by actinobacteria, mainly from the genus Streptomyces. The multidrug resistance observed in pathogenic microorganisms and tumor cells lead to the need for new antibacterial and antitumor drugs . Endophytic actinobacteria have shown great potential in the search for bioactive natural products. This work describes the chemical study of two endophytic actinobacteria strains: Streptomyces sp. RTd 22 and Streptomyces sp RTD 31, isolated from Tithonia diversifolia roots. Active fractions in biological assays were further fractionated for identifying the bioactive compounds, which are: the macrolide antibiotics concanamycins (S31-1) and B (S31-2), anhydrous aglycones of concanamycins A (S31-3) and B (S31-4), all four produced by Streptomyces sp. RTd31, and the ionophore polyether grisorixin (S22-2), produced by Streptomyces sp. RTd22. The production of these bioactive compounds was monitored by UPLC-MS via the SIM mode. Concanamycins A and B had maximum production at 96 h, and grisorixin at 192 h. Other compounds identified by the dereplication of buthanolic extracts of both actinobacteria were the siderophore norcardamine (S31-7) and deoxy-nocardamine (S31-8), the siderophores desferrioxamine B (S31-9) was identified only in buthanolic extracts of Streptomyces sp RTd31. Experiments varying media and co-culture were tested to stimulate the biosynthesis of novel compounds, but nothing new was identified. By genome sequencing of Streptomyces sp RTd22 and antiSMASH analysis it was possible to verify the presence of several biosynthetic clusters in the genome of this strain. It was possible to identify the biosynthetic clusters of himastatin (S22-4) and its analogous compound coelichelin (S22-5); however, these compounds were not biosynthesized in the culture conditions used. The grisorixin biosynthetic cluster was determined, and homologous recombination was performed for deleting the analogue gene of nigericin flavin monooxygenase nigCI. Two mutants were obtained, and one of them was cultured for analyzing its metabolic profile by mass spectrometry. There was no production of grisorixin or its possible precursor by the mutant, but others compounds were produced.

O estudo das interações planta-microrganismos tem sido de grande interesse ao longo dos últimos anos. Atualmente, as interações que ocorrem entre microrganismos que vivem em estreita relação também vêm merecendo grande atenção, pois forças competitivas e mutualísticas podem induzir a produção de novos metabólitos bioativos. Portanto, estudar interações existentes entre os microrganismos endofíticos que colonizam uma mesma planta parece ser uma estratégia promissora para a obtenção de substâncias quimicamente diferentes, eventualmente bioativas. Através da utilização de culturas mistas de microrganismos, o presente trabalho contribuiu para o conhecimento da relação existente entre os fungos endofíticos SS13 (Papulaspora immersa), SS50 (Fusarium oxysporum), SS67 (Nigrospora sphaerica), SS77 (Alternaria tenuissima) e SS84 (Phoma betae), isolados da planta medicinal Smallanthus sonchifolius (yacon), e sua implicação no aumento da diversidade química de produtos naturais microbianos, com o intuito de se identificar metabólitos secundários anticancerígenos. Para isso, os fungos foram cultivados em culturas singles e mistas em meios de cultivo líquidos e semi-sólidos. Foram utilizados diferentes meios de cultura, diferentes maneiras de se estabelecer o cultivo misto e diferentes formas de extração. Os extratos foram analisados química e biologicamente. Após fracionamento, foram isoladas cinco substâncias: afidicolina (I), 3-desóxi-afidicolina (II), estenfiperilenol (III), alterperilenol (IV) e alternariol monometil éter (V), sendo as duas primeiras de origem terpênica e as outras de origem policetídica. As substâncias I e II foram produzidas pelo fungo SS67, sendo que a produção de I aparentemente aumentou nas culturas mistas líquidas com SS13 e SS84, diminuindo consideravelmente na cultura mista com SS77. Devido à afidicolina ser um composto altamente citotóxico, os cultivos do fungo SS67 originaram extratos muito ativos frente aos ensaios de citotoxicidade em células cancerígenas. A substância III, primeiramente, só foi detectada por CLAE-DAD na cultura mista dos fungos SS67 e SS77, e a produção da substância IV foi maior nessa cultura mista que na cultura simples do fungo SS77 (meio fermentativo de extrato de malte). Provavelmente esses compostos foram produzidos por SS77 em resposta à presença de SS67. O extrato obtido durante esse cultivo misto foi o que apresentou maior atividade citotóxica frente à linhagem celular MDAMB-435 (câncer de mama). Posteriormente, a substância III foi também isolada da cultura simples do fungo SS77 cultivado em outras condições (meio fermentativo PDB), juntamente com a substância V. Os experimentos de antagonismo em placa de Petri envolvendo esses dois fungos revelaram, ainda, a presença de vários outros compostos na zona de inibição, que não correspondem às substâncias previamente isoladas de meio líquido, e podem ser responsáveis pelo efeito antagônico observado em meio semi-sólido. Os experimentos de atividade antagônica dos metabólitos produzidos pelos fungos evidenciaram que muitos compostos ativos, provavelmente, são produzidos em quantidades ínfimas, o que impossibilita a detecção por CLAE-DAD. Além disso, verificou-se que a substância I não possui atividade antifúngica significativa contra os fungos SS13, SS50 e SS77 e que a inibição de SS67 por SS77 ocorre devido à produção de compostos difusíveis em meio semi-sólido, e ainda, muito provavelmente, pela produção da substância III e IV em meio líquido, além de outros policetídeos. A produção de metabólitos secundários por fungos endofíticos deve ocorrer em consequência do papel ecológico que desempenham na natureza. Assim, a utilização de culturas mistas desses microrganismos deve induzir a produção de compostos que não seriam produzidos em condições não naturais. / The study of plant-microbe interactions has been of great interest over the past years. Currently, the interactions that occur among organisms that live in close relationship also have been receiving great attention because mutualistic and competitive forces may induce the production of new bioactive metabolites. Therefore, studying the interactions between endophytic microorganisms that colonize the same plant seems to be a promising strategy for obtaining chemically different substances that might also be bioactive. Through the utilization of mixed microbial cultures, this study contributed to knowledge of the relationship among the endophytic fungi SS13 (Papulaspora immersa), SS50 (Fusarium oxysporum), SS67 (Nigrospora sphaerica), SS77 (Alternaria tenuissima) and SS84 (Phoma betae), isolated from the medicinal plant Smallanthus sonchifolius (yacon), and its role in the increase of the chemical diversity of microbial natural products, in order to identify anticancer secondary metabolites. For this aim, the fungi were grown in single and mixed cultures, both in liquid and semi-solid media. Different media, different approaches to establish the mixed cultures and different extraction methods were used. The extracts were analyzed chemically and biologically. After the fractionation, five compounds were isolated: aphidicolin (I), 3-deoxy-aphidicolin (II), stemphyperylenol (III), alterperylenol (IV) and alternariol monomethyl ether (V). Compounds I and II are terpene derivatives, while III, IV and V are polyketide derivatives. The substances I and II were produced by the fungus SS67, and the production of I apparently increased in liquid mixed cultures with SS13 and SS84, decreasing considerably in mixed culture with SS77. Due to the high cytotoxic activity of aphidicolin (I), the cultures of the fungus SS67 originated extracts highly active in the cytotoxicity assays in cancer cells. Substance III was only detected by HPLC-DAD in the mixed culture between the fungi SS67 and SS77, and the production of compound IV was higher in this mixed culture when compared to the single culture of the fungus SS77 (malt extract medium). Probably these compounds were produced by SS77 in response to the presence of SS67. The extract obtained during this mixed culture showed the highest cytotoxic activity against the cell line MDAMB-435 (breast cancer). In a subsequent fermentation in PDB medium, compound III was also isolated from the single culture of the fungus SS77 grown, along with compound V. Additionally, antagonism experiments in Petri dishes with these two fungi revealed the presence of several other compounds in the inhibition zone, which does not correspond to the substances previously isolated from the liquid medium, and may be responsible for the antagonistic effect observed in semi-solid medium. The experiments of antagonistic activity of metabolites produced by fungi showed that many active compounds are probably produced in very small quantities, making it impossible to detect by HPLC-DAD. Moreover, it was found that aphidicolin (I) did not have significant antifungal activity against the fungi SS13, SS50 and SS77 and that the SS67 inhibition by SS77 is due to the production of diffusible compounds in semi-solid medium, and likely, due to the production of compound III and IV in liquid medium, and other polyketides. The production of secondary metabolites by endophytic fungi probably occurs as a result of the ecological role they play in nature. Thus, the use of mixed cultures of these microorganisms may induce the production of compounds that would not be produced under unnatural conditions.

The species composition of planktonic communities is determined not only by abiotic factors, such as nutrient availability, temperature, and water column stratification but also by biotic interactions between hosts and parasites, predators and prey, and among competitors. Blooms of the red tide dinoflagellate, Karenia brevis, can dramatically alter the planktonic community, reaching densities of millions of cells per liter and occurring nearly monospecifically. I investigated whether K. brevis uses chemical compounds to defend against grazing or to inhibit the growth of competitors. Because K. brevis is known to produce brevetoxins which act as potent neurotoxins in mammals, I also investigated whether brevetoxins played a role in competition or predator resistance. Experiments revealed that copepods fed diets rich in Karenia brevis experienced lowered fitness, however, nutritional inadequacy, rather than toxicity, was responsible for the decrease in grazer fitness. Compounds exuded from natural samples of K. brevis blooms did, however, inhibit the growth of four of five model competitors. Compounds exuded from K. brevis cultures were similarly allelopathic to competitors. Exposure to these allelopathic compounds resulted in lowered photosynthetic efficiency of all competitors, and decreased cell membrane integrity of three competitors. The allelopathic potency of K. brevis blooms was variable between collections and years, but allelopathy did not correlate with bloom density or concentration of brevetoxins. However, the variability of allelopathy could partially be explained by the presence of specific competitors. The diatom Skeletonema costatum reduced the growth-inhibiting effects of K. brevis bloom exudates, suggesting that S. costatum has a mechanism for undermining K. brevis allelopathy. Allelopathic compounds exuded by K. brevis that inhibited the growth of the diatom Asterionellopsis glacialis were partially characterized. K. brevis produced multiple, polar, organic compounds that inhibited A. glacialis growth. Exuded brevetoxins, on the other hand, had no effect on A.glacialis growth. Taken together, these results indicate that K. brevis is not chemically defended against grazing, but does produce yet-unidentified allelopathic compounds that inhibit the growth of competing phytoplankton. Blooms of K. brevis may be facilitated by the exudation of potent allelopathic compounds, but the specific phytoplankton assemblage has the potential to alter bloom dynamics.

Thesis (Ph.D.)--Flinders University, Dept. of Chemistry. / Typescript bound. Includes bibliographical references: (p. 360-369) Also available online.

Os micro-organismos são profícuas fontes de produtos naturais bioativos. Diversos fármacos de importância clínica são de origem microbiana, sendo que a maioria dos antibióticos usados clinicamente é produzida por actinobactérias, principalmente do gênero Streptomyces. A resistência a múltiplas drogas por microorganismos patogênicos e também pelas células tumorais leva à necessidade por novos fármacos antibacterianos e antitumorais. Actinobactérias endofíticas têm demonstrado grande potencial para a busca de produtos naturais bioativos. O presente trabalho relata o estudo químico de duas linhagens de actinobactérias endofíticas, Streptomyces sp. RTd 22 e Streptomyces sp RTd 31, isoladas das raízes de Tithonia diversifolia. As frações ativas nos ensaios biológicos foram fracionadas para a identificação dos compostos bioativos, sendo eles os antibióticos macrolídeos concanamicinas A (S31-1) e B (S31-2), anidro-agliconas das concanamicinas A (S31-3) e B (S31-4), todos produzidos por Streptomyces sp RTd31, e o ionóforo poliéter grisorixina (S22-2), produzido por Streptomyces sp. RTd22. Foi realizado o monitoramento da produção desses compostos bioativos por UPLC-MS através do modo SIM. As concanamicinas A e B tiveram um máximo de produção com 96h, já a grisorixina obteve um máximo com 192h. Outros compostos identificados por desreplicação dos extratos butanólicos de ambas as actinobactérias foram os sideróforos norcardamina (S31-7) e desoxi-nocardamina (S31-8), já o sideróforo desferrioxamina B (S31-9) foi identificado apenas nos extratos butanólicos de Streptomyces sp RTd31. Experimentos de variação do meio de cultivo e co-cultura com bactérias patogênicas foram empregados a fim de estimular a biossíntese de novos compostos, porém nenhum novo metabólito foi identificado. O sequenciamento genético da actinobactéria Streptomyces sp. RTd22 permitiu verificar a presença de vários clusters biossintéticos nesse micro-organismo através da análise feita pelo antiSMASH. Foi possível identificar o cluster da himastatina (S22-4) e da coeliquelina (S22-5), sendo que ambos os compostos não foram biossintetizados nas condições de cultivo utilizadas. O cluster biossintético da grisorixina foi determinado e o experimento de recombinação homóloga para a deleção do gene análogo a flavina mono-oxigenase da nigericina nigC foi realizado. Dois mutantes foram obtidos e um deles foi cultivado para a análise do perfil metabólico por espectrometria de massas. Não houve a produção da grisorixina nem do seu possível precursor pelo mutante, mas outros metabólitos foram produzidos / Microorganisms are prolific sources of bioactive natural products. Several clinically important drugs have microbial origin, and most of the therapeutically used antibiotics are produced by actinobacteria, mainly from the genus Streptomyces. The multidrug resistance observed in pathogenic microorganisms and tumor cells lead to the need for new antibacterial and antitumor drugs . Endophytic actinobacteria have shown great potential in the search for bioactive natural products. This work describes the chemical study of two endophytic actinobacteria strains: Streptomyces sp. RTd 22 and Streptomyces sp RTD 31, isolated from Tithonia diversifolia roots. Active fractions in biological assays were further fractionated for identifying the bioactive compounds, which are: the macrolide antibiotics concanamycins (S31-1) and B (S31-2), anhydrous aglycones of concanamycins A (S31-3) and B (S31-4), all four produced by Streptomyces sp. RTd31, and the ionophore polyether grisorixin (S22-2), produced by Streptomyces sp. RTd22. The production of these bioactive compounds was monitored by UPLC-MS via the SIM mode. Concanamycins A and B had maximum production at 96 h, and grisorixin at 192 h. Other compounds identified by the dereplication of buthanolic extracts of both actinobacteria were the siderophore norcardamine (S31-7) and deoxy-nocardamine (S31-8), the siderophores desferrioxamine B (S31-9) was identified only in buthanolic extracts of Streptomyces sp RTd31. Experiments varying media and co-culture were tested to stimulate the biosynthesis of novel compounds, but nothing new was identified. By genome sequencing of Streptomyces sp RTd22 and antiSMASH analysis it was possible to verify the presence of several biosynthetic clusters in the genome of this strain. It was possible to identify the biosynthetic clusters of himastatin (S22-4) and its analogous compound coelichelin (S22-5); however, these compounds were not biosynthesized in the culture conditions used. The grisorixin biosynthetic cluster was determined, and homologous recombination was performed for deleting the analogue gene of nigericin flavin monooxygenase nigCI. Two mutants were obtained, and one of them was cultured for analyzing its metabolic profile by mass spectrometry. There was no production of grisorixin or its possible precursor by the mutant, but others compounds were produced.